TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Incyte Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals
STOCKS

After Soaring to $150, Can Incyte Stir Up More Upside?

Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap (Friday 1/13/17)
JIM CRAMER

Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap

Largest U.S. Banks Bullish About M&A Despite Lackluster 2016
MERGERS AND ACQUISITIONS

Merger frenzy is on: What to expect in 2017

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking
JIM CRAMER

These Stocks Are Too Hot, in a Bad Way : Jim Cramer's 'Mad Money' Recap

So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
FUTURES

So the Nasdaq is at a historical high but the Dow is going opposite direction

The Real Apple of the Dow's Eye -- ICYMI
STOCKS

The Real Apple of the Dow's Eye -- ICYMI

San Francisco Power Outage Affects 90,000
STOCKS

The Monday sights, sounds and biotech buzz from the J.P. Morgan Healthcare Conference

Wall Street's Decline Puts Record-Making Streak in Jeopardy
FUTURES

Nasdaq hits records even as crude selloff sours rest of market

Facebook Makes Powerful Move Higher -- How to Trade It, Along With 6 Other Active Stocks
STOCKS

Facebook makes powerful move higher -- how to trade it, along with 6 other active stocks

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal
VIDEO

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

Midday Report: Ariad Pharmaceuticals Jumps on Deal; Dow Takes Pause on Road to 20,000
VIDEO

Midday Report: Ariad Pharmaceuticals Jumps on Deal; Dow Takes Pause on Road to 20,000

Takeda Pays $5.2 Billion for Leukemia Drug Maker Ariad, Ending Months of Takeout Speculation
STOCKS

Takeda pays $5.2B for leukemia drug maker Ariad

Wall Street's Decline Puts Record-Making Streak in Jeopardy
FUTURES

Dow steps back from 20,000 as crude oil slides

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
STOCKS

Biotech stocks surge Monday amid flurry of deal activity

Market Selloff Strategies: Cramer's 'Mad Money' Recap (Friday 8/18/17)
FUTURES

Stock futures mostly lower as crude oil slides

JPMorgan Earnings
STOCKS

What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017

17 Thoughts on Biotech Stocks to Kick Off 2017
STOCKS

17 thoughts on biotech stocks to kick off 2017

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)
STOCKS

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

2016 Was a Terrible Year for Biotech but the Tweets Were on Point
STOCKS

2016 was a terrible year for biotech but the tweets were on point

Market Scorecard: 2017 Is Great for Stocks Except in China
FUTURES

Dow scores another record for third day in a row

5 Things You Must Know Before the Market Opens Wednesday
FUTURES

Dow at session highs in broad Wall Street rally

S&P 500 and Dow Reverse Losses to Post Intraday Records
FUTURES

S&P 500 reverses loss to post intraday record

'Mad Money' Lightning Round: 'Health Care Is All Over the Map'
JIM CRAMER

'Mad Money' Lightning Round: 'Health Care Is All Over the Map'

Jim Cramer's 'Mad Money' Recap: Markets Pivot From Shocked to Bullish
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Markets Pivot From Shocked to Bullish

Incyte, Skyworks Solutions, Western Digital, Constellation Brands: 'Mad Money' Lightning Round
STOCKS

Why Incyte's shares could soon hit $100